Arena Pharmaceuticals reported $-131019000 in EBITDA for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Acadia Pharmaceuticals ACAD:US $ -65.88M 0.4M
Alnylam Pharmaceuticals ALNY:US $ -173.65M 10.18M
Amgen AMGN:US $ 2970M 89M
Arena Pharmaceuticals ARNA:US $ -131.02M 3.32M
Biogen BIIB:US $ 1147.6M 41.7M
Biomarin Pharmaceutical BMRN:US $ 55.4M 60.14M
Cara Therapeutics CARA:US $ -23498000 101.85M
Eisai 4523:JP Y 3543M 29237M
Esperion Therapeutics ESPR:US $ -82671000 12.74M
Gilead Sciences GILD:US $ 3418M 332M
GlaxoSmithKline GSK:LN 2042M 224M
Halozyme Therapeutics HALO:US $ 51.47M 26.95M
Intercept Pharmaceuticals ICPT:US $ -28.32M 10.83M
Intra Cellular Therapies ITCI:US $ -53.09M 8.12M
Ligand Pharmaceuticals LGND:US $ 16.92M 9.78M
Ptc Therapeutics PTCT:US $ -84.56M 0.59M
Regeneron Pharmaceuticals REGN:US $ 1180.1M 48.6M
Sarepta Therapeutics SRPT:US $ -132.94M 30.49M
Tg Therapeutics TGTX:US $ -89.14M 2.41M
Therapeuticsmd TXMD:US -28189000 6.15M
United Therapeutics UTHR:US $ -29.2M 107.6M
Vanda Pharmaceuticals VNDA:US $ 11.06M 1.81M
YTE INCY:US $ 120.19M 73.23M
Ziopharm Oncology ZIOP:US $ -21.02M 1.33M